API CDMO - Process Development and Technology Transfer

Evonik’s Drug Substance product line delivers comprehensive process development and technology transfer services to support pharmaceutical innovators from clinical development through commercialization. Our R&D centers specialize in de novo process design, process optimization, and the smooth transfer of existing processes into our manufacturing network. Integrated thermal safety assessments, scale-up modeling, and risk-based quality evaluations ensure robustness, reproducibility, and regulatory readiness at every stage.